[Pneumoperitoneum with systemic sclerosis].
We report a case of systemic sclerosis (SSc) complicated with benign pneumoperitoneum without apparent pneumatosis cystoides intestinalis (PCI). A 43-year-old woman was admitted to our hospital because of prominent abdominal distension in April 1997. Raynaud's phenomenon has been detected since 1991. She was suffering from recurrent diarrhea, constipation, and subileus. The diagnosis of SSc was made in 1996 based on the sclerosis in her face, forearms, and chest, and hypomotility of the esophagus. On admission, she presented no signs of peritoneal irritation. The laboratory data revealed that white blood cell count was 7,400/mm3 and C-reactive protein was 0.1 mg/dl. Chest and abdominal roentgenograms showed massive free air under the diaphragm, dilatation of small and large intestine, and air-fluid level. PCI was not apparent. Pneumoperitoneum was improved after four weeks with intravenous hyperalimentation. But she presented recurrent severe diarrhea and high fever whenever she tried to take food orally. Klebsiella pneumoniae was proved in her jejunal juice by bacteriologic examination. Intravenous prostaglandin F2 alpha and oral fosfomycin calcium intake made her condition better. Benign pneumoperitoneum without PCI is rarely reported in the patients with SSc. In her condition, weakness of intestinal wall, hypomotility of intestine, unusual bacterial overgrowth, and elevated intraluminal pressure made intraluminal gas go through the wall of the fragile intestine of SSc. As operation of intestine of SSc usually cause miserable outcome, pneumoperitoneum accompanied with SSc even if PCI is apparent or not must be treated with conventional manner while there is no signs of peritoneal irritation.
Division of Rheumatic Diseases, Tokyo Metropolitan Ohtsuka Hospital.
A
A
Nakajima
Y
Y
Koseki
A
A
Suwa
H
H
Imaeda
T
T
Okamura
M
M
Tsutsumino
W
W
Sendo
C
C
Terai
M
M
Hara
S
S
Kashiwazaki
S
S
Inada
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015237:Dinoprost / Q000627:therapeutic use; D004386:Duodenum / Q000382:microbiology; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use; D006801:Humans; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D011006:Pneumatosis Cystoides Intestinalis; D011027:Pneumoperitoneum / Q000188:drug therapy / Q000209:etiology*; D012595:Scleroderma, Systemic / Q000150:complications*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D015237:Dinoprost